On October 29, the U.S. Food and Drug Administration (FDA) authorized the emergency use (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for children 5 to 11 years of age.
A “newly” released official document from Pfizer, dated October 26th (Ref.1. page 14 vaccine formula), shows that this ‘new’ version of the COVID vaccine contains a new ingredient, Tromethamine (Tris). This Tris buffer is used to replace previously used phosphate-buffered saline (PBS) buffer.
Tris buffer is used commonly in research labs to stabilize the pH value of many laboratory reagents and solutions. Its medical indication is to bring blood pH to normal limit (7.35-7.45) and to correct metabolic acidosis (blood pH dropped below to normal limit due to infection or other metabolic conditions).
Any chemical or drug has its side effect. Tris has many known side effects, including inflammation of blood vessels, reduction of the blood sugar level, depression, liver cell damage, and more (see ref. 2).
For more details on Pfizer’s clinical trial of the COVID Children vaccine, please see reference 3 for the problems of its clinical trial on children aged 5-11, in terms of sample size (750 children) and follow-up length (17 days after 2nd dose).
Knowing this, do you still consider putting your children through this experimental genetic agent?
Reference;
- https://www.fda.gov/media/153447/download
- https://www.drugs.com/cdi/tromethamine.html
- https://theexpose.uk/2021/11/01/pfizer-adds-ingredient-to-vaccine-for-kids-that-treats-heart-attacks/